Ezt az oldalt automatikusan lefordították, és a fordítás pontossága nem garantált. Kérjük, olvassa el a angol verzió forrásszöveghez.

Preterm Infant Transport Stress (PremiTranS) Study (PremiTranS)

2017. szeptember 11. frissítette: University of Nottingham

Preterm Infant Transport Stress (PremiTranS) Study - A Feasibility Study of the Impact of Inter-hospital Transport on the Preterm Infant

This is an observational pilot study to quantify the amount of vibration, noise, physiological and biochemical instability that premature babies are exposed to during inter-hospital transport.

A tanulmány áttekintése

Állapot

Befejezve

Körülmények

Részletes leírás

Neonatal intensive care has advanced significantly in recent years resulting in a marked decrease in mortality, especially in the extremely low birth weight (ELBW) infants (<1000g). However, we have not observed a parallel improvement in long term outcomes such as neurological disability as observed with the EPICure and EPICure 2 data.

There is a need to explore new avenues in neonatal care that can reduce the long term neurodevelopment complications of extremely preterm birth. One area that has received little attention is that of inter-hospital transfer of these preterm babies. In the UK, like other countries such as USA and Australia, the centralisation of neonatal intensive care in large tertiary units (NICU's) has resulted in reduced mortality but not significant morbidity. Data from Australia suggests there is 4-fold increase in death for those ELBW infants transferred between tertiary neonatal units within the same city (Melbourne). Furthermore, data from the USA, where 69,000 neonatal transports occur each year, have demonstrated a significant increase in severe intraventricular haemorrhages (IVH) in transported infants. Severe IVH is associated with a poor neurological outcome including cerebral palsy. Many of the ELBW infants are transferred within a few hours of life in order to receive specialist care and services. However, it is the first few days of life that represent the greatest risk of developing an IVH with up to 50% developing IVH before 3 days and if severe 75% could go on to develop cerebral palsy.

No causation has been identified for the associated significant increase in risk of IVH and it is likely to be multifactorial. Such factors could include resuscitation at birth and early care on the NICU. However, in developed countries some of these factors are likely to be less important with the establishment of neonatal networks (sharing common practice and guidelines) and international and national guidelines/training programmes for newborn resuscitation. This raises the actual transfer of the preterm infant which could represent a significant stress to the infant. Inter-hospital transfer, usually many miles away from the birth hospital, is at a time during early life when transition from fetus to newborn is still occurring and there is often cardiorespiratory instability. The combination of these factors can increase the risk of neurological injury to the immature developing brain, especially during the period of greatest risk of IVH. Although IVH is easy to identify and define as a risk to the long term neurodevelopment of the baby there is also the possibility that more subtle neurological injury can occur. Such injury may not be detectable from ultrasound imaging alone but may require novel biochemical markers that can be detected in the bodily fluids (blood, urine) or by more detailed imaging techniques (magnetic resonance imaging - MRI). A recent study has highlighted this with early markers of stress correlating with poor neurological predictors, such as regional alterations in brain volume (on MRI) and functional motor deficits, in ex-preterm infants at term corrected gestation.

As more ELBW infants are reaching school age, there are growing concerns surrounding the increased in incidence of neurodevelopmental problems in these children. Many predict that such problems may stem from early life exposure to environmental stressors which could potentially have adverse effects on the infant's physiological and neurological stability. The presence of these stressors is very much evident during inter-hospital transportation and on neonatal units where preterm infants are exposed to noise and mechanical vibration.

On all neonatal units, the characteristic loud noises contributed by alarms, ventilators, phones and even conversations often exceed the recommended hourly level of 45 decibels on an A-weighted scale. Excessive noise levels have been shown to increase heart rate in both preterm and term infants. A maturing biphasic pattern with initial cardiac acceleration and rebound deceleration has been observed in higher birth weight infants, this which was absent or milder in ELBW infants. Noise has also been shown to increase blood pressure, increase respiratory rates, and affect sleep cycles. Decreased autonomic and self-regulatory abilities make these ELBW infants vulnerable to high noise levels due to their inability to filter and process noxious stimuli. This could potentially hinder neurodevelopment during such a critical time.

During inter-hospital transfers, infants are continually exposed to prolonged, low-frequency, high amplitude mechanical vibration. This mechanical vibration has been shown to exceed the maximum recommended limit (0.31m/s) for adults. In adult humans and experimental animals this vibration was found to have adverse effects on the cardiovascular function, the nervous system, the thermoregulatory functions, metabolic and endocrine function, and gastrointestinal system. In animal models, short periods of vibration, similar to those experienced by transported infants, there is a deleterious effect on surfactant and respiratory function which is again often requiring support in the early part of a preterm infants life. The implications of vibration may be especially relevant when transporting ELBW infants as it could compromise the stability and observation of the infant in transport.

Whilst the focus on transport is to ensure the safety of the infant we must also explore interventions that can increase comfort, reduce physical stress and improve outcomes. No studies have detailed the combined physical, physiological and biochemical effects of inter-hospital transfer on these infants and their outcomes. Indeed, many studies have documented sound exposure and a limited number have documented vibration (albeit of the transport incubator rather than the baby). None of these studies have addressed this in a detailed and structured way that will allow us to plan interventional strategies aimed at reducing these stressors. Until such detailed data is available it is not possible to undertake trials aimed at reducing the impact of inter-hospital transfer with the aim of improving outcomes.

The present study will be the first to examine the physical forces the baby is exposed to during transfer. We will also combine this with measures of physiological stability (i.e. monitor vital signs and correlate these with physical stressors) as well as measure key biochemical markers in the newborn. These biochemical markers include cortisol (a well described marker of short-term stress)32, copeptin (a marker of newborn stress) and s100b protein in the urine (a marker of neurological injury). Outcome data will also be analysed.

STUDY OBJECTIVES AND PURPOSE Hypothesis Inter-hospital transfer of the ELBW infant in the first days of life will adversely impact on measures of neonatal stress in the short-term.

Aims

The Primary aim is to quantify:

(i) physical stresses experienced by preterm infants during inter-hospital transfer in early life,

Secondary aims are to quantify:

(ii) the physiological and biochemical disruption caused by transfer, (iii) central nervous system dynamics using advanced computational modelling to ascertain the potential impact on brain injury.

STUDY DESIGN This is an observational study that will provide feasibility data for a larger interventional trial with appropriate sample size.

The study has 3 elements:

Study A. Using infant mannequins we will undertake standard inter-hospital journeys similar to those currently undertaken by neonatal transport teams. The mannequin will be equipped with motion detection equipment (accelerometers), positioning devices (GPS) and noise meters. We will examine a number of interventions aimed at reducing transport associated motion. This work will allow us to plan future trials aimed at improving transport comfort, safety and practicality in preterm infants.

Study B. Establish the motion experienced by neonatal patients during current transport methods. This element of the study will quantify multi-directional forces experienced by babies during their transfer. Whilst data is available on vibration of the transport incubator, no study has quantified the actual effects on the baby and the response of key physiological observations (e.g. heart rate and oxygen saturation). Data from this element will capture a range of clinical variables such as gestation, weight and level of support. This data, along with that gathered in Study C, will allow us to develop a computational model of the physical stresses experienced and design better transport systems.

Study C. To quantify, correlate and assess the physiological and biochemical disturbance experienced by preterm infants undergoing inter-hospital transfer. Preterm infants undergoing inter-hospital transfer will be included in this element.

Tanulmány típusa

Megfigyelő

Beiratkozás (Tényleges)

30

Kapcsolatok és helyek

Ez a rész a vizsgálatot végzők elérhetőségeit, valamint a vizsgálat lefolytatásának helyére vonatkozó információkat tartalmazza.

Tanulmányi helyek

      • Nottingham, Egyesült Királyság, NG72UH
        • Nottingham University Hospitals NHS Trust

Részvételi kritériumok

A kutatók olyan embereket keresnek, akik megfelelnek egy bizonyos leírásnak, az úgynevezett jogosultsági kritériumoknak. Néhány példa ezekre a kritériumokra a személy általános egészségi állapota vagy a korábbi kezelések.

Jogosultsági kritériumok

Tanulmányozható életkorok

30 perc (Gyermek)

Egészséges önkénteseket fogad

Nem

Tanulmányozható nemek

Összes

Mintavételi módszer

Nem valószínűségi minta

Tanulmányi populáció

Hospital born preterm infants

Leírás

Inclusion Criteria:

  • <31 weeks gestation
  • <= 3 days old

Exclusion Criteria:

  • major congenital abnormality
  • survival unlikely

Tanulási terv

Ez a rész a vizsgálati terv részleteit tartalmazza, beleértve a vizsgálat megtervezését és a vizsgálat mérését.

Hogyan készül a tanulmány?

Tervezési részletek

Kohorszok és beavatkozások

Csoport / Kohorsz
Preterm inter-hospital transfers
preterm infants <31 weeks gestation and <=day 3 of life
Preterm infants inborn
Preterm infants <31 weeks gestation and <=3 days old born and remaining at same hospital.
Ex-preterm infants back transfered
Mature ex-preterm infants transferred back to referring hospital

Mit mér a tanulmány?

Elsődleges eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Quantification of whole body vibration
Időkeret: during transfer
Use of multi-axis accelerometers to quantify vibration and shocks experienced by the head, body and incubator. Calculation of A(8) according to ISO.
during transfer

Másodlagos eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Noise exposure
Időkeret: During transfer
Measure total noise exposure (dBA) during transfer compared with NICU exposure.
During transfer
Cranial ultrasound imaging to quantify/identify intraventricular haemorrhage
Időkeret: First 28 days of life
IVH assessment by cranial USS
First 28 days of life
Evidence of excess stress or neuronal injury
Időkeret: first week following transfer
Plasma Copeptin and urinary S100b measurements
first week following transfer
Quantification of stresses during first week of life
Időkeret: 7 days of life
Validated stressor score
7 days of life
NIRS measurement of cerebral saturations
Időkeret: During ambulance transfer
Use of NIRS during interhopsital transfer to assess cerebral saturations when compared to control area (thigh)
During ambulance transfer

Együttműködők és nyomozók

Itt találhatja meg a tanulmányban érintett személyeket és szervezeteket.

Nyomozók

  • Kutatásvezető: Don Sharkey, PhD, University of Nottingham

Tanulmányi rekorddátumok

Ezek a dátumok nyomon követik a ClinicalTrials.gov webhelyre benyújtott vizsgálati rekordok és összefoglaló eredmények benyújtásának folyamatát. A vizsgálati feljegyzéseket és a jelentett eredményeket a Nemzeti Orvostudományi Könyvtár (NLM) felülvizsgálja, hogy megbizonyosodjon arról, hogy megfelelnek-e az adott minőség-ellenőrzési szabványoknak, mielőtt közzéteszik őket a nyilvános weboldalon.

Tanulmány főbb dátumok

Tanulmány kezdete

2013. június 1.

Elsődleges befejezés (Tényleges)

2017. augusztus 31.

A tanulmány befejezése (Tényleges)

2017. szeptember 1.

Tanulmányi regisztráció dátumai

Először benyújtva

2013. május 8.

Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak

2013. május 8.

Első közzététel (Becslés)

2013. május 10.

Tanulmányi rekordok frissítései

Utolsó frissítés közzétéve (Tényleges)

2017. szeptember 12.

Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak

2017. szeptember 11.

Utolsó ellenőrzés

2017. január 1.

Több információ

A tanulmányhoz kapcsolódó kifejezések

Egyéb vizsgálati azonosító számok

  • 12063

Terv az egyéni résztvevői adatokhoz (IPD)

Tervezi megosztani az egyéni résztvevői adatokat (IPD)?

NEM

Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .

3
Iratkozz fel